![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 5
Zeitschriftenartikel
Strube, Wolfgang; Aksar, Aslihan; Bauer, Ingrid; Barbosa, Susana; Benros, Michael; Blankenstein, Christiane; Campana, Mattia; Davidovic, Laetitia; Glaichenhaus, Nicolas; Falkai, Peter; Gorlitz, Thomas; Hansbauer, Maximilian; Heilig, Daniel; Khalfallah, Olfa; Leboyer, Marion; Martinuzzi, Emanuela; Mayer, Susanne; Moussiopoulou, Joanna; Papazova, Irina; Peric, Natasa; Wagner, Elias; Schneider-Axmann, Thomas; Simon, Judit und Hasan, Alkomiet
(2022):
Effects of add-on Celecoxib treatment on patients with schizophrenia spectrum disorders and inflammatory cytokine profile trial (TargetFlame): study design and methodology of a multicentre randomized, placebo-controlled trial.
In: Journal of Neural Transmission, Bd. 130, Nr. 8: S. 1039-1048
Hansbauer, Maximilian und Strauss, Catharina
(2021):
Severe serotonin syndrome under duloxetine in a patient with coeliac disease - Is there a connection? A case report.
In: European Journal of Psychiatry, Bd. 35, Nr. 3: S. 193-196
Hasan, Alkomiet; Roeh, Astrid; Leucht, Stefan; Langguth, Berthold; Hansbauer, Maximilian; Oviedo-Salcedo, Tatiana; Kirchner, Sophie K.; Papazova, Irina; Loehrs, Lisa; Wagner, Elias; Maurus, Isabel; Strube, Wolfgang; Rossner, Moritz J.; Wehr, Michael C.; Bauer, Ingrid; Heres, Stephan; Leucht, Claudia; Kreuzer, Peter M.; Zimmermann, Stephanie; Schneider-Axmann, Thomas; Goerlitz, Thomas; Karch, Susanne; Egert-Schwender, Silvia; Schossow, Beate; Rothe, Philipp und Falkai, Peter
(2020):
Add-on spironolactone as antagonist of the NRG1-ERBB4 signaling pathway for the treatment of schizophrenia: Study design and methodology of a multicenter randomized, placebo-controlled trial.
In: Contemporary Clinical Trials Communications, Bd. 17, 100537
Hansbauer, Maximilian; Wagner, Elias; Strube, Wolfgang; Roeh, Astrid; Padberg, Frank; Keeser, Daniel; Falkai, Peter und Hasan, Alkomiet
(2020):
rTMS and tDCS for the treatment of catatonia: A systematic review.
In: Schizophrenia Research, Bd. 222: S. 73-78
Hansbauer, Maximilian; Wobrock, Thomas; Kunze, Birgit; Langguth, Berthold; Landgrebe, Michael; Eichhammer, Peter; Frank, Elmar; Cordes, Joachim; Woelwer, Wolfgang; Winterer, Georg; Gäbel, Wolfgang; Hajak, Goeran; Ohmann, Christian; Verde, Pablo E.; Rietschel, Marcella; Ahmed, Raees; Honer, William G.; Malchow, Berend; Strube, Wolfgang; Schneider-Axmann, Thomas; Falkai, Peter 
ORCID: https://orcid.org/0000-0003-2873-8667 und Hasan, Alkomiet
(2018):
Efficacy of high-frequency repetitive transcranial magnetic stimulation on PANSS factors in schizophrenia with predominant negative symptoms - Results from an exploratory re-analysis.
In: Psychiatry Research, Bd. 263: S. 22-29
ORCID: https://orcid.org/0000-0003-2873-8667 und Hasan, Alkomiet
(2018):
Efficacy of high-frequency repetitive transcranial magnetic stimulation on PANSS factors in schizophrenia with predominant negative symptoms - Results from an exploratory re-analysis.
In: Psychiatry Research, Bd. 263: S. 22-29